Market Place
Sourcing Support
The French speciality pharmaceutical, Juvisé acquires two onco products from AZ
20 Dec 2020 //
PRESS RELEASE
AstraZeneca sells Amrimidx and Casodex European rights to Juvise
21 Dec 2019 //
PHARMAFILE
Pfizer, Astellas` Xtandi racks up more data for new prostate cancer approval
03 Jun 2019 //
FIERCE PHARMA
Anvisa Suspends Batch of Casodex (bicalutamide) 50mg
24 Feb 2018 //
ANVISA
ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
30 Dec 2017 //
PR NEWSWIRE
AZ books 3 percent sales drop for Q3
09 Nov 2017 //
PHARMA TIMES
US FDA Approves Xtandi Capsules for Advanced Prostate Cancer
25 Oct 2016 //
PHARMABIZ
FDA Approves Supplemental New Drug Application for XTANDI Capsules
21 Oct 2016 //
PRNEWSWIRE
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Journal of Clinical Oncology Publishes the STRIVE trial of enzalutamide
26 Jan 2016 //
PRNEWSWIRE
Lancet Oncology Publishes Results from the Phase 2 TERRAIN Trial of enzalutamide
13 Jan 2016 //
PR NEWS WIRE
Apotex` Generic Bicalutamide (50 Mg) Approved in US For Prostate Cancer
23 May 2015 //
FDA
FDA Warns vs 20 Unregistered Drugs
23 Mar 2015 //
INQUIRER.NET
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.